CompletedPhase 4NCT03071575

Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age

Studying Congenital rubella syndrome

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Centers for Disease Control and Prevention
Principal Investigator
K. Zaman, MD, M.D
International Centre for Diarrhoeal Disease Research, Bangladesh
Intervention
Measles-rubella (MR) vaccine at 6 months of age(biological)
Enrollment
637 enrolled
Eligibility
All sexes
Timeline
2017 – 2018

Study locations (1)

Collaborators

International Centre for Diarrhoeal Disease Research, Bangladesh · Ministry of Health and Family Welfare, Bangladesh

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03071575 on ClinicalTrials.gov

Other trials for Congenital rubella syndrome

Additional recruiting or active studies for the same condition.

See all trials for Congenital rubella syndrome →

← Back to all trials